Bayindir-Buchhalter, I.* ; Wolff, G.* ; Lerch, S.* ; Sijmonsma, T.* ; Schuster, M.* ; Gronych, J.* ; Billeter, A.T.* ; Babaei, R.* ; Krunic, D.* ; Ketscher, L.* ; Spielmann, N. ; Hrabě de Angelis, M. ; Ruas, J.L.* ; Müller-Stich, B.P.* ; Heikenwalder, M.* ; Lichter, P.* ; Herzig, S. ; Vegiopoulos, A.*
Cited4 is a sex-biased mediator of the antidiabetic glitazone response in adipocyte progenitors.
EMBO Mol. Med. 10:e8613 (2018)
Most antidiabetic drugs treat disease symptoms rather than adipose tissue dysfunction as a key pathogenic cause in the metabolic syndrome and type 2 diabetes. Pharmacological targeting of adipose tissue through the nuclear receptor PPARg, as exemplified by glitazone treatments, mediates efficacious insulin sensitization. However, a better understanding of the context-specific PPARg responses is required for the development of novel approaches with reduced side effects. Here, we identified the transcriptional cofactor Cited4 as a target and mediator of rosiglitazone in human and murine adipocyte progenitor cells, where it promoted specific sets of the rosiglitazone-dependent transcriptional program. In mice, Cited4 was required for the proper induction of thermogenic expression by Rosi specifically in subcutaneous fat. This phenotype had high penetrance in females only and was not evident in beta-adrenergically stimulated browning. Intriguingly, this specific defect was associated with reduced capacity for systemic thermogenesis and compromised insulin sensitization upon therapeutic rosiglitazone treatment in female but not male mice. Our findings on Cited4 function reveal novel unexpected aspects of the pharmacological targeting of PPARg.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Adipocyte Progenitors ; Browning ; Cited4 ; Glitazones ; Insulin Sensitivity; Activated Receptor-gamma; White Adipose-tissue; Ppar-gamma; Insulin-resistance; Skeletal-muscle; Rosiglitazone Treatment; Mitochondrial Biogenesis; Uncoupling Protein-1; Diabetic-patients; Brown Adipocytes
Keywords plus
Language
english
Publication Year
2018
Prepublished in Year
HGF-reported in Year
2018
ISSN (print) / ISBN
1757-4676
e-ISSN
1757-4684
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 10,
Issue: 7,
Pages: ,
Article Number: e8613
Supplement: ,
Series
Publisher
Wiley
Publishing Place
Chichester
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30201 - Metabolic Health
90000 - German Center for Diabetes Research
Research field(s)
Genetics and Epidemiology
Helmholtz Diabetes Center
PSP Element(s)
G-500600-001
G-500692-001
G-501900-251
Grants
Copyright
Erfassungsdatum
2018-07-11